Skip to Content

BlackRock Health Sciences Opps Svc SHISX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 70.89  /  +1.29 %
  • Total Assets 8.6 Bil
  • Adj. Expense Ratio
    1.140%
  • Expense Ratio 1.140%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 5,000
  • Status Open
  • TTM Yield 0.18%
  • Turnover 29%

USD | NAV as of Mar 02, 2024 | 1-Day Return as of Mar 02, 2024, 1:59 AM GMT+0

Morningstar’s Analysis SHISX

Will SHISX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

BlackRock Health Sciences Opps Svc’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHISX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 48.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

UnitedHealth Group Inc

8.80 731.3 Mil
Healthcare

Eli Lilly and Co

8.75 726.4 Mil
Healthcare

AbbVie Inc

5.07 421.5 Mil
Healthcare

Boston Scientific Corp

4.77 396.4 Mil
Healthcare

Merck & Co Inc

4.66 387.0 Mil
Healthcare

Amgen Inc

3.98 330.3 Mil
Healthcare

Abbott Laboratories

3.56 295.7 Mil
Healthcare

Danaher Corp

3.14 260.7 Mil
Healthcare

Stryker Corp

2.73 227.0 Mil
Healthcare

Intuitive Surgical Inc

2.71 225.1 Mil
Healthcare